Martyn D. Williams

Technology Services

Commercial Services

Profile

Martyn D.
Williams worked as the Chief Executive Officer and Executive Director at Ark Therapeutics Group Plc from 2012 to 2012.
He also worked as the Chief Financial Officer at Walsh International, Inc.

Former positions of Martyn D. Williams

Companies	Position	End
Ark Therapeutics Group Plc Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom.	President	2012-07-30
Walsh International, Inc. Walsh International, Inc. Information Technology ServicesTechnology Services Part of IQVIA Holdings, Inc., Walsh International, Inc. is a company that develops marketing and sales information systems. The company is based in Newtown, PA. Walsh International was acquired by Cognizant Corp on August 31, 1998 for $184.63 million.	Director of Finance/CFO	-

See the detail of Martyn D. Williams's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martyn D. Williams's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Walsh International, Inc. Walsh International, Inc. Information Technology ServicesTechnology Services Part of IQVIA Holdings, Inc., Walsh International, Inc. is a company that develops marketing and sales information systems. The company is based in Newtown, PA. Walsh International was acquired by Cognizant Corp on August 31, 1998 for $184.63 million.	Technology Services
Ark Therapeutics Group Plc Ark Therapeutics Group Plc Miscellaneous Commercial ServicesCommercial Services Ark Therapeutics Group Plc is a gene-based medicine company, which is engaged in the discovery, development and commercialization of products in areas of specialist medicine, with particular focus on vascular disease and cancer. The company was founded by Peter Stephen Keen, John W. Martin, Seppo Ylä-Herttuala, Stephen Barker and Kenneth Powell in July 1997 and is headquartered in London, the United Kingdom.	Commercial Services